Funding partners

We believe that national and international collaboration is vital to speed up the pace of research, and that pooling resources achieves more.

For that reason, we have established links with like-minded advocates and charities across rhe UK, continental Europe, North America and Australia, and seek to work collaboratively wherever possible.

Solving Kids' Cancer (US)

Our strategic relationship with Solving Kids’ Cancer in New York enables us to jointly benefit from a truly international presence and perspective. We are able to leverage knowledge and relationships on both sides of the Atlantic to maximise our impact, influence, and the benefit we bring to children with neuroblastoma.

Other funding partners

Our established funding partners include:

Together, we have collectively committed almost £2,000,000 to collaborative projects, funding clinical research studies that will be of direct benefit to children with neuroblastoma in the UK. It provides innovative therapeutic options closer to home for children for whom standard therapy has not been successful and eliminates the need - or perceived need - for some families to fundraise and travel outside the UK.

Fund research with Solving Kids' Cancer

If you would like to understand more about our collaborative approach to research funding or if you are interested in exploring opportunities for future collaborative research efforts, please get in touch with us via email at [email protected]

Latest

100 Miles for Jessica

To help raise money for critical treatment for Jessica Butler
Lucy’s Skydive for Jude

I am taking on this challenge to fundraise to help get my son, Jude, to target to access the bivalent vaccine in New York
Raffle for Jude

Jude is 4. He lives in Sheffield with his family. He is battling cancer & needs pioneering treatment in America. We can help get him there…
Rock N Roll for Kayla

Kayla from Norwich is facing a huge challenge, so rock n rollers unite.

Beau's Campaign

Beau was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in December 2020. Her family are appealing for your help to raise £317,000 by May 2022.
Flora's Campaign

In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma. Her family are appealing for your help to raise £252,000 by August 2022 for Flora to enrol on the Bivalent Vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Jude's Campaign

Jude is a Dinosaur and animal-loving three-year-old. In July 2021 Jude was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.
Joseph Yeandle

We are devastated to share the news that beautiful Joseph has sadly passed away.
Maysaa's Campaign

Four-year-old Maysaa was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in March 2021. Her family are asking for your support to raise £106,000 by August 2022 for Maysaa to enrol on the DFMO study in Charlotte that aims to stop her neuroblastoma from coming back.
Chloe’s Journey

Beautiful Chloe passed away on the 4th of February 2022.
Eden's Campaign

Six-year-old Eden was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in April 2021.
Kayla's Campaign

Three-year-old Kayla was diagnosed with high-risk neuroblastoma in May 2021. Kayla’s parents are asking for your help to raise £221,000 by November 2022 for Kayla to enrol on the bivalent vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Peter's Campaign

11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. Thanks to your incredible fundraising and support, Peter was able to enrol on the DFMO study in Charlotte at the end of January 2022.
Dulcie's Campaign

In December 2021, five-year-old Dulcie was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.